Prabir Chakravarty
About
In The Last Decade
Prabir Chakravarty
20 papers receiving 346 citations
Peers
Comparison fields: 5 of 58
- Oncology 216
- Immunology 172
- Molecular Biology 98
- Pulmonary and Respiratory Medicine 53
- Radiology, Nuclear Medicine and Imaging 51
Countries citing papers authored by Prabir Chakravarty
This map shows the geographic impact of Prabir Chakravarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prabir Chakravarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prabir Chakravarty more than expected).
Fields of papers citing papers by Prabir Chakravarty
This network shows the impact of papers produced by Prabir Chakravarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prabir Chakravarty. The network helps show where Prabir Chakravarty may publish in the future.
Co-authorship network of co-authors of Prabir Chakravarty
This figure shows the co-authorship network connecting the top 25 collaborators of Prabir Chakravarty. A scholar is included among the top collaborators of Prabir Chakravarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prabir Chakravarty. Prabir Chakravarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 37 | |
| 6 | 0 | |
| 7 | Cancer vaccine; problems and promises. | 1 |
| 8 | 33 | |
| 9 | 32 | |
| 10 | 5 | |
| 11 | 18 | |
| 12 | Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. | 177 |
| 13 | 6 | |
| 14 | 3 | |
| 15 | 6 | |
| 16 | 6 | |
| 17 | 1 | |
| 18 | 9 | |
| 19 | 3 | |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.